These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 18559538
1. Role of PELP1/MNAR signaling in ovarian tumorigenesis. Dimple C, Nair SS, Rajhans R, Pitcheswara PR, Liu J, Balasenthil S, Le XF, Burow ME, Auersperg N, Tekmal RR, Broaddus RR, Vadlamudi RK. Cancer Res; 2008 Jun 15; 68(12):4902-9. PubMed ID: 18559538 [Abstract] [Full Text] [Related]
2. Emerging significance of ER-coregulator PELP1/MNAR in cancer. Nair S, Vadlamudi RK. Histol Histopathol; 2007 Jan 15; 22(1):91-6. PubMed ID: 17128415 [Abstract] [Full Text] [Related]
3. Modulation of in situ estrogen synthesis by proline-, glutamic acid-, and leucine-rich protein-1: potential estrogen receptor autocrine signaling loop in breast cancer cells. Rajhans R, Nair HB, Nair SS, Cortez V, Ikuko K, Kirma NB, Zhou D, Holden AE, Brann DW, Chen S, Tekmal RR, Vadlamudi RK. Mol Endocrinol; 2008 Mar 15; 22(3):649-64. PubMed ID: 18079323 [Abstract] [Full Text] [Related]
6. Extranuclear functions of ER impact invasive migration and metastasis by breast cancer cells. Chakravarty D, Nair SS, Santhamma B, Nair BC, Wang L, Bandyopadhyay A, Agyin JK, Brann D, Sun LZ, Yeh IT, Lee FY, Tekmal RR, Kumar R, Vadlamudi RK. Cancer Res; 2010 May 15; 70(10):4092-101. PubMed ID: 20460518 [Abstract] [Full Text] [Related]
11. Altered Expression of ESR1, ESR2, PELP1 and c-SRC Genes Is Associated with Ovarian Cancer Manifestation. Englert-Golon M, Andrusiewicz M, Żbikowska A, Chmielewska M, Sajdak S, Kotwicka M. Int J Mol Sci; 2021 Jun 09; 22(12):. PubMed ID: 34207568 [Abstract] [Full Text] [Related]
12. Functional implications of altered subcellular localization of PELP1 in breast cancer cells. Vadlamudi RK, Manavathi B, Balasenthil S, Nair SS, Yang Z, Sahin AA, Kumar R. Cancer Res; 2005 Sep 01; 65(17):7724-32. PubMed ID: 16140940 [Abstract] [Full Text] [Related]
14. Absence of estrogen receptor-alpha expression in human ovarian clear cell adenocarcinoma compared with ovarian serous, endometrioid, and mucinous adenocarcinoma. Fujimura M, Hidaka T, Kataoka K, Yamakawa Y, Akada S, Teranishi A, Saito S. Am J Surg Pathol; 2001 May 01; 25(5):667-72. PubMed ID: 11342781 [Abstract] [Full Text] [Related]
15. Insulin-like growth factor-binding protein 2 and 5 are differentially regulated in ovarian cancer of different histologic types. Wang H, Rosen DG, Wang H, Fuller GN, Zhang W, Liu J. Mod Pathol; 2006 Sep 01; 19(9):1149-56. PubMed ID: 16729015 [Abstract] [Full Text] [Related]
16. Therapeutic targeting of PELP1 prevents ovarian cancer growth and metastasis. Chakravarty D, Roy SS, Babu CR, Dandamudi R, Curiel TJ, Vivas-Mejia P, Lopez-Berestein G, Sood AK, Vadlamudi RK. Clin Cancer Res; 2011 Apr 15; 17(8):2250-9. PubMed ID: 21421858 [Abstract] [Full Text] [Related]